z-logo
open-access-imgOpen Access
Industry Update
Author(s) -
Peter Timmins
Publication year - 2015
Publication title -
therapeutic delivery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.619
H-Index - 46
eISSN - 2041-6008
pISSN - 2041-5990
DOI - 10.4155/tde.14.103
Subject(s) - diabetic macular edema , medicine , ophthalmology , diabetic retinopathy , diabetes mellitus , endocrinology
September 2014, the period covered by this article, was characterized by continued prospective and actual acquisition activity and some big possible deals such as Valeant and Allergan, were still in prospect. A number of drug approvals for medicines with novel therapeutic targets such as anti-PD-1 for oncology or employing delivery technologies such as corticosteroid intravitreal implants for diabetic macular edema were announced during the month.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom